2.04
price up icon5.70%   0.11
pre-market  プレマーケット:  2.06   0.02   +0.98%
loading

Nautilus Biotechnology Inc (NAUT) 最新ニュース

pulisher
Jan 21, 2025

Barclays PLC Buys 47,059 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

Jeff Bezos Stock Portfolio: Top Investment Picks - CoinCodex

Jan 20, 2025
pulisher
Jan 17, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 14.2% in December - MarketBeat

Jan 17, 2025
pulisher
Jan 15, 2025

Barclays PLC Has $1.04 Million Holdings in Northfield Bancorp, Inc. (Staten Island, NY) (NASDAQ:NFBK) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Sells 25,020 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 15, 2025
pulisher
Jan 10, 2025

US Penny Stocks To Watch In January 2025 - Simply Wall St

Jan 10, 2025
pulisher
Jan 09, 2025

Dermata Therapeutics Inc (DRMA): Major Improvements, Worth A Look - Stocks Register

Jan 09, 2025
pulisher
Jan 06, 2025

Barclays PLC Has $303,000 Stock Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 06, 2025
pulisher
Jan 01, 2025

State Street Corp Lowers Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 01, 2025
pulisher
Dec 18, 2024

The Manufacturers Life Insurance Company Invests $67,000 in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Dec 18, 2024
pulisher
Dec 12, 2024

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St

Dec 12, 2024
pulisher
Dec 09, 2024

With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future - Yahoo Finance

Dec 09, 2024
pulisher
Dec 08, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Cut to “Sell” at The Goldman Sachs Group - Defense World

Dec 08, 2024
pulisher
Dec 06, 2024

Goldman Sachs Downgrades Nautilus Biotechnology (NAUT) - MSN

Dec 06, 2024
pulisher
Dec 05, 2024

Goldman Sachs cuts Nautilus Biotechnology stock to sell By Investing.com - Investing.com Canada

Dec 05, 2024
pulisher
Dec 05, 2024

Goldman Sachs cuts Nautilus Biotechnology stock to sell - Investing.com

Dec 05, 2024
pulisher
Dec 01, 2024

Nautilus Biotechnology Inc (NAUT-Q) QuotePress Release - The Globe and Mail

Dec 01, 2024
pulisher
Nov 24, 2024

Nautilus Biotechnology Reports Q3 2024 Financial Results - MSN

Nov 24, 2024
pulisher
Nov 23, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.8% – Here’s What Happened - Defense World

Nov 23, 2024
pulisher
Nov 23, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Shares Up 0.8%What's Next? - MarketBeat

Nov 23, 2024
pulisher
Nov 07, 2024

3 US Penny Stocks With Market Caps Up To $400M - Simply Wall St

Nov 07, 2024
pulisher
Nov 01, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - BioSpace

Nov 01, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World

Oct 30, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology reports Q3 EPS (13c), consensus (16c) - TipRanks

Oct 29, 2024
pulisher
Oct 22, 2024

Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Oct 22, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Acquires 9,459 Shares of Toro Corp. (NASDAQ:TORO) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Has $358,000 Stock Holdings in Standard Lithium Ltd. (NYSE:SLI) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Oct 12, 2024
pulisher
Oct 10, 2024

Nautilus Biotechnology Inc. - Scrip

Oct 10, 2024
pulisher
Oct 09, 2024

We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 - The Manila Times

Oct 08, 2024
pulisher
Oct 04, 2024

nautilus biotechnology, inc. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Sep 29, 2024

Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down - MSN

Sep 27, 2024
pulisher
Sep 25, 2024

Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Caxton Associates LP Acquires 131,589 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World

Sep 25, 2024
pulisher
Sep 20, 2024

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech

Sep 20, 2024
pulisher
Sep 19, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India

Sep 19, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada

Sep 18, 2024
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
大文字化:     |  ボリューム (24 時間):